GSA Capital Partners’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,797
| Closed | -$75K | – | 1918 |
|
|
2023
Q3 | $75K | Sell |
3,797
-6,082
| -62% | -$120K | 0.01% | 1401 |
|
|
2023
Q2 | $756K | Buy |
9,879
+2,526
| +34% | +$193K | 0.08% | 473 |
|
|
2023
Q1 | $695K | Buy |
7,353
+971
| +15% | +$91.8K | 0.07% | 512 |
|
|
2022
Q4 | $621K | Buy |
6,382
+2,328
| +57% | +$227K | 0.08% | 467 |
|
|
2022
Q3 | $1.05M | Sell |
4,054
-2,207
| -35% | -$569K | 0.14% | 136 |
|
|
2022
Q2 | $1.17M | Buy |
6,261
+4,711
| +304% | +$877K | 0.17% | 95 |
|
|
2022
Q1 | $152K | Buy |
+1,550
| New | +$152K | 0.02% | 1231 |
|
|
2017
Q2 | – | Sell |
-71
| Closed | -$67K | – | 1944 |
|
|
2017
Q1 | $67K | Buy |
+71
| New | +$67K | ﹤0.01% | 1684 |
|
|
2016
Q2 | – | Sell |
-319
| Closed | -$355K | – | 1904 |
|
|
2016
Q1 | $355K | Buy |
319
+202
| +173% | +$225K | 0.02% | 1212 |
|
|
2015
Q4 | $146K | Buy |
117
+43
| +58% | +$53.7K | 0.01% | 1698 |
|
|
2015
Q3 | $100K | Sell |
74
-55
| -43% | -$74.3K | ﹤0.01% | 1656 |
|
|
2015
Q2 | $233K | Buy |
+129
| New | +$233K | 0.01% | 1750 |
|